stockrow
Friday 6 November 2026
Export BHVN’s income statement to Excel — free account
Biohaven Ltd.
BHVN Healthcare Biotechnology
- EPS
- +47.8%
- Free cash flow
- +26.6%
- Total debt
- −1.48%
Quarter to September 2026, against a year earlier
14.31
0.41
+2.95%
Follow BHVN
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.57 | 4.28 | 6.68 | 2.75 | |
Current Ratio |
3.05 | 4.73 | 7.41 | 3.18 | |
Net Debt/EBITDA |
(0.83) | 0.07 | 0.83 | 0.57 | |
Debt/Assets |
100.23% | 69.99% | 51.87% | 52.92% | |
Debt/Equity |
(2.69) | 21.23 | 1.87 | 4.59 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.83 | 0.62 | 1.15 | 0.90 | |
Capex/Depreciation |
(0.08) | (0.20) | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.08 | 0.05 | 0.04 | 0.04 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.71) | (0.56) | (1.02) | (1.21) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.71) | (0.57) | (1.02) | (1.21) | |
Cash per Share |
1.07 | 1.78 | 2.36 | 2.97 | |
Shareholders Equity per Share |
(0.65) | 0.08 | 0.88 | 0.48 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.65) | 0.08 | 0.88 | 0.48 | |
Free Cash Flow |
(107.03) | (85.55) | (149.92) | (130.67) | |
Working Capital |
128.75 | 233.90 | 333.57 | 252.40 | |
Capital Expenditures |
(0.18) | (0.45) | — | (0.01) | |
Net Current Asset Value |
(170.41) | (61.96) | 48.74 | (31.05) | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
0.00 | 0.00 | — | 0.00 | |
| Other line items | |||||
Average Payables |
15.51 | 15.87 | 14.78 | 14.84 | |
Average Assets |
336.40 | 460.58 | 462.68 | 533.28 | |
Average Common Equity |
(57.70) | 73.40 | 194.50 | 237.75 |
Columns are period end dates · fundamentals updated 2 Nov 2026